Discordance Among Transient Elastography, Aspartate Aminotransferase to Platelet Ratio Index, and Histologic Assessments of Liver Fibrosis in Patients With Chronic Hepatitis C

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 3, 2013, Pages

  Gara, Naveen ^a   Zhao, Xiongce ^a   Kleiner, David E ^b   Liang, T Jake ^a   Hoofnagle, Jay H ^a   Ghany, Marc G ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

AUROC; Cancer Risk; HCV; Liver Disease

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ELASTOGRAPHY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; RATING SCALE; SCORING SYSTEM; SENSITIVITY AND SENSIBILITY; THROMBOCYTE;

EID: 84874581137     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.10.044     Document Type: Article

References (33)

1. Dienstag J.L. The role of liver biopsy in chronic hepatitis C. Hepatology 2002, 36:S152-S160.
2. Saadeh S., Cammell G., Carey W.D., et al. The role of liver biopsy in chronic hepatitis C. Hepatology 2001, 33:196-200.
3. Gebo K.A., Herlong H.F., Torbenson M.S., et al. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 2002, 36:S161-S172.
4. Seeff L.B., Everson G.T., Morgan T.R., et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 2010, 8:877-883.
5. Regev A., Berho M., Jeffers L.J., et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002, 97:2614-2618.
6. Bedossa P., Dargère D., Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003, 38:1449-1457.
7. Colloredo G., Guido M., Sonzogni A., et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003, 39:239-244.
8. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994, 20:15-20.
9. Smith J.O., Sterling R.K. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Aliment Pharmacol Ther 2009, 30:557-576.
10. Lin Z.H., Xin Y.N., Dong Q.J., et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 2011, 53:726-736.
11. Klibansky D.A., Mehta S.H., Curry M., et al. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J Viral Hepat 2012, 19:e184-e193.
12. Malik R., Lai M., Sadiq A., et al. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis. J Gastroenterol Hepatol 2010, 25:1562-1568.
13. Nudo C.G., Jeffers L.J., Bejarano P.A., et al. Correlation of laparoscopic liver biopsy to elasticity measurements (FibroScan) in patients with chronic liver disease. J Gastroenterol Hepatol 2008, 4:862-870.
14. Kirk G.D., Astemborski J., Mehta S.H., et al. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection. Clin Infect Dis 2009, 48:963-972.
15. Wai C.T., Greenson J.K., Fontana R.J., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003, 38:518-526.
16. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22:696-699.
17. Talwalkar J.A., Kurtz D.M., Schoenleber S.J., et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2007, 5:1214-1220.
18. Friedrich-Rust M., Ong M.F., Martens S., et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008, 134:960-974.
19. Carrión J.A., Navasa M., Bosch J., et al. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transplant 2006, 12:1791-1798.
20. Vizzutti F., Arena U., Romanelli R.G., et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007, 45:1290-1297.
21. Bureau C., Metivier S., Peron J.M., et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 2008, 27:1261-1268.
22. Lemoine M., Katsahian S., Ziol M., et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther 2008, 28:1102-1110.
23. Masuzaki R., Tateishi R., Yoshida H., et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 2009, 49:1954-1961.
24. Masuzaki R., Tateishi R., Yoshida H., et al. Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography. J Clin Gastroenterol 2008, 42:839-843.
25. Chang H.K., Park Y.J., Koh H., et al. Hepatic fibrosis scan for liver stiffness score measurement: a useful preendoscopic screening test for the detection of varices in postoperative patients with biliary atresia. J Pediatr Gastroenterol Nutr 2009, 49:323-328.
26. Foucher J., Chanteloup E., Vergniol J., et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006, 55:403-408.
27. Castéra L., Foucher J., Bernard P.H., et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010, 51:828-835.
28. Lucidarme D., Foucher J., Le Bail B., et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009, 49:1083-1089.
29. Myers R.P., Crotty P., Pomier-Layrargues G., et al. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int 2010, 30:1471-1480.
30. Myers R.P., Pomier-Layrargues G., Kirsch R., et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 2012, 55:199-208.
31. Myers R.P., Pomier-Layrargues G., Kirsch R., et al. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol 2012, 56:564-570.
32. de Lédinghen V., Wong V.W., Vergniol J., et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan. J Hepatol 2012, 56:833-839.
33. de Lédinghen V., Vergniol J., Foucher J., et al. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int 2010, 30:1043-1048.